Changes in expression of lymphocyte amyloid precursor protein mRNA isoforms in normal aging and Alzheimer's disease

被引：14

作者：

Ebstein, RP ^{[1
]}

Nemanov, L ^{[1
]}

Lubarski, G ^{[1
]}

Dano, M ^{[1
]}

Trevis, T ^{[1
]}

Korczyn, AD ^{[1
]}

机构：

[1] TEL AVIV UNIV,SACKLER SCH MED,DEPT NEUROL,IL-69978 TEL AVIV,ISRAEL

来源：

MOLECULAR BRAIN RESEARCH | 1996年 / 35卷 / 1-2期

关键词：

aging; Alzheimer's disease; amyloid precursor protein mRNA; amyloid precursor protein; reverse-transcriptase PCR; alternative splicing;

D O I：

10.1016/0169-328X(95)00227-J

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

We measured, by employing a quantitative reverse-transcriptase PCR procedure, the relative (to beta-actin) levels of amyloid precursor protein APP(751) and APP(770) mRNA isoforms in lymphocytes obtained from 64 cognitively intact subjects ranging in ages from 20 to 91 years and in 19 patients with sporadic Alzheimer's disease. A positive correlation was observed between the relative lymphocyte APP(751) mRNA levels and subject age for the cognitively intact cohort. No difference in lymphocyte APP(751) mRNA levels was observed between Alzheimer's disease patients and their age-matched controls (> 55 years of age). However, the ratio of lymphocyte APP(751):APP(770) mRNA levels was significantly lower in Alzheimer's disease subjects compared to the > 55-year-old cohort. This decreased ratio is most likely due to an average 31% increase in the lymphocyte APP(770) isoform in Alzheimer's disease patients compared to 12% in the > 55-year-old cognitively intact group. Marked individual differences in amount of APP mRNA isoforms were encountered among all the subject groups and in the less than or equal to 55-year-old cohort, a 10-fold variation in individual APP(751) mRNA levels was observed. The relevance of these findings in lymphocytes to the pathogenesis of Alzheimer's disease is discussed.

引用

页码：260 / 268

页数：9

共 56 条

[1] SELECTIVE INDUCTION OF KUNITZ-TYPE PROTEASE INHIBITOR DOMAIN-CONTAINING AMYLOID PRECURSOR PROTEIN MESSENGER-RNA AFTER PERSISTENT FOCAL ISCHEMIA IN RAT CEREBRAL-CORTEX [J].

ABE, K ;

TANZI, RE ;

KOGURE, K .

NEUROSCIENCE LETTERS, 1991, 125 (02) :172-174

[2] ALZHEIMERS-DISEASE - BETA-AMYLOID PRECURSOR PROTEIN MESSENGER-RNA EXPRESSION IN MONONUCLEAR BLOOD-CELLS [J].

ALLEN, JS ;

MURPHY, GM ;

ENG, LF ;

STULTZ, KE ;

DAVIES, HD ;

PICKFORD, LB ;

TINKLENBERG, JR .

NEUROSCIENCE LETTERS, 1991, 132 (01) :109-112

[3] EXACT CLEAVAGE SITE OF ALZHEIMER AMYLOID PRECURSOR IN NEURONAL PC-12 CELLS [J].

ANDERSON, JP ;

ESCH, FS ;

KEIM, PS ;

SAMBAMURTI, K ;

LIEBERBURG, I ;

ROBAKIS, NK .

NEUROSCIENCE LETTERS, 1991, 128 (01) :126-128

[4]

BURDICK D, 1992, J BIOL CHEM, V267, P546

[5]

BUSH AI, 1990, J BIOL CHEM, V265, P15977

[6]

Bush Ashley I., 1993, V695, P175

[7] INVITRO FORMATION OF AMYLOID FIBRILS FROM 2 SYNTHETIC PEPTIDES OF DIFFERENT LENGTHS HOMOLOGOUS TO ALZHEIMERS-DISEASE BETA-PROTEIN [J].

CASTANO, EM ;

GHISO, J ;

PRELLI, F ;

GOREVIC, PD ;

MIGHELI, A ;

FRANGIONE, B .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1986, 141 (02) :782-789

[8] EXCESSIVE PRODUCTION OF AMYLOID BETA-PROTEIN BY PERIPHERAL CELLS OF SYMPTOMATIC AND PRESYMPTOMATIC PATIENTS CARRYING THE SWEDISH FAMILIAL ALZHEIMER-DISEASE MUTATION [J].

CITRON, M ;

VIGOPELFREY, C ;

TEPLOW, DB ;

MILLER, C ;

SCHENK, D ;

JOHNSTON, J ;

WINBLAD, B ;

VENIZELOS, N ;

LANNFELT, L ;

SELKOE, DJ .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (25) :11993-11997

[9] AGING AND DEFECTIVE LYMPHOID-CELL ACTIVATION [J].

COFFMAN, FD ;

COHEN, S .

EXPERIMENTAL GERONTOLOGY, 1989, 24 (5-6) :437-449

[10] INFLAMMATORY MECHANISMS IN ALZHEIMERS-DISEASE [J].

EIKELENBOOM, P ;

ZHAN, SS ;

VANGOOL, WA ;

ALLSOP, D .

TRENDS IN PHARMACOLOGICAL SCIENCES, 1994, 15 (12) :447-450

← 1 2 3 4 5 6 →